Insulet | PODD - Trade Debtors

Stock Price
241.40
Daily Change
-1.75 -0.72%
Monthly
-19.31%
Yearly
-14.72%
Q1 Forecast
247.93

Insulet reported $462.2M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Abbott USD 10.4B 166M Sep/2025
Align Technology USD 1.1B 2.38M Dec/2025
AtriCure USD 62.98M 3.02M Sep/2025
Avanos Medical USD 111.5M 1.3M Sep/2025
Baxter International USD 1.77B 127M Jun/2025
Becton, Dickinson and Co. USD 2.99B 51M Sep/2025
Boston Scientific USD 2.83B 13M Sep/2025
Cardinal Health USD 13.66B 108M Dec/2025
Cooper Companies USD 829M 36.7M Sep/2025
Dexcom USD 1.11B 267.4M Sep/2025
Edwards Lifesciences USD 902.6M 150.7M Jun/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Globus Medical USD 688.12M 28M Sep/2025
ICU Medical USD 191.54M 2.02M Sep/2025
Insulet USD 462.2M 17.8M Sep/2025
Integra LifeSciences USD 262.16M 22.35M Sep/2025
J&J USD 17.61B 235M Sep/2025
Masimo USD 355.9M 69.4M Sep/2025
Medtronic USD 6.26B 252M Jun/2025
Merit Medical Systems USD 231.51M 7.27M Sep/2025
Roche Holding CHF 11.9B 460M Dec/2025
Solventum Corp USD 1.18B 79M Sep/2025
Stryker USD 4.04B 396M Dec/2025
Tandem Diabetes Care USD 125.94M 2.5M Sep/2025
Teleflex USD 592.65M 78.84M Sep/2025
West Pharmaceutical Services USD 625M 42.6M Sep/2025
Zimmer Biomet Holdings USD 1.6B 13M Sep/2025